Opioid-induced preconditioning: recent advances and future perspectives.
about
Opioid-induced cardioprotectionCurrent research on opioid receptor function.Cholesterol reduction by methyl-beta-cyclodextrin attenuates the delta opioid receptor-mediated signaling in neuronal cells but enhances it in non-neuronal cellsThe effect of passive opium smoking on cardiovascular indices of rabbits with normal and ischemic heartsDelta opioid receptors: the link between exercise and cardioprotection.Remifentanil ameliorates intestinal ischemia-reperfusion injuryThe relationship of opium addiction with coronary artery diseaseRole of morphine preconditioning and nitric oxide following brain ischemia reperfusion injury in mice.Extracellular signalling molecules in the ischaemic/reperfused heart - druggable and translatable for cardioprotection?Inhalational anesthetics as preconditioning agents in ischemic brain.Reperfusion injury: does it exist?Impaired p38 MAPK/HSP27 signaling underlies aging-related failure in opioid-mediated cardioprotection.Coronary vasoregulation in health and diseaseTransport of the synthetic opioid peptide DADLE ([D-Ala2,D-Leu5]-enkephalin) in neuronal cells.Morphine: a protective or destructive role in neurons?Delta opioid receptor and its peptide: a receptor-ligand neuroprotectionEfficacy of cardioprotective 'conditioning' strategies in aging and diabetic cohorts: the co-morbidity conundrum.Neuroprotection against hypoxia/ischemia: δ-opioid receptor-mediated cellular/molecular events.Genetics and genomics of ischemic tolerance: focus on cardiac and cerebral ischemic preconditioning.The role of remote ischemic preconditioning in the treatment of atherosclerotic diseases.Preconditionin effects of dexmedetomidine on myocardial ischemia/reperfusion injury in ratsRemote ischaemic conditioning-a new paradigm of self-protection in the brain.Caveolin-1/-3: therapeutic targets for myocardial ischemia/reperfusion injury.Delta Opioid Receptors and Cardioprotection.The opioid antagonist, beta-funaltrexamine, inhibits chemokine expression in human astroglial cells.Opioid Facilitation of β-Adrenergic Blockade: A New Pharmacological Condition?Response to thrombolytic agents in acute myocardial infarction in opium abusers versus non-abusers.Stereological study of the effects of morphine consumption and abstinence on the number of the neurons and oligodendrocytes in medial prefrontal cortex of rats.Impact of remifentanil use on early postoperative outcomes following brain tumor resection or rectal cancer surgery.Relationship between opioid therapy, tissue-damaging procedures, and brain metabolites as measured by proton MRS in asphyxiated term neonates.Delta Opioid Receptor and Peptide: A Dynamic Therapy for Stroke and Other Neurological Disorders.Preserved cardiac mitochondrial function and reduced ischaemia/reperfusion injury afforded by chronic continuous hypoxia: role of opioid receptors.κ-Opioid receptors are involved in enhanced cardioprotection by combined fentanyl and limb remote ischemic postconditioning.Myocardial protection induced by fentanyl in pigs exposed to high-dose adrenaline.Remifentanil preconditioning alleviating brain damage of cerebral ischemia reperfusion rats by regulating the JNK signal pathway and TNF-α/TNFR1 signal pathway.Effects of Remifentanil Pretreatment on Bupivacaine Cardiotoxicity in Rats.Isoflurane and other commonly used anaesthetics do not protect the isolated buffer perfused mouse heart from ischemia-reperfusion injury.Morphine-alcohol treatment impairs cognitive functions and increases neuro-inflammatory responses in the medial prefrontal cortex of juvenile male rats.Myocardial Opioid Receptors in Conditioning and Cytoprotection.
P2860
Q27006830-DEC41901-0E78-4B0F-B343-8FB6D7248DF5Q27693220-A94BEE9B-DAAB-49B2-B1E9-56D52934CD56Q28578357-9432CA50-AFF4-46EF-9D38-4916E3927FCAQ33635348-F097A698-7ACD-462F-A949-32245B20147FQ34557326-F9304B97-3418-46B9-83A1-8681C169E724Q34680534-DB0BB96E-CFF0-4E0E-A14C-F3E8F5BDC119Q34786618-CD96A560-D8EC-489B-AFBC-814A73CF4B0CQ35197827-FF1CB874-B951-4B0C-AA59-4AC26917951CQ35286339-E40DAAD9-07B5-4009-8242-EDAFA7EA109DQ36478937-D1A8AA6D-1138-4F17-ABCE-92932BC40977Q36636752-D38210D5-BF7A-4AEB-BD34-CF681475020EQ36813494-CFCCE59A-25ED-4149-A18E-2DCA5D2DB803Q36969052-FC7C0116-D280-4881-943D-E785E2EA19FBQ37009402-E9FC1CEB-D8B0-4C8C-964D-1376AC504A6DQ37113199-5787870F-C644-4B15-BA2F-19E13F483570Q37225038-634D1CF8-CCDC-489C-8CB9-F9C9616F4B1AQ37871976-D20D83BA-1831-486A-B87F-0BE43791C15AQ38046756-E66B505E-12AB-4094-AB46-0D0A3C6E28ADQ38061499-1AE50BDA-0C92-4EAE-89B1-858BA3EA217AQ38173375-D949A0CD-6478-40DE-9FF5-DE5E467FA92EQ38560054-D51801DE-CB43-4C1F-A6D2-2D05B6034889Q38639332-CC7F224D-FE9F-4565-88D8-823F4318B1C5Q38855645-07A05608-C1DF-439E-8C66-4F65274F74AFQ39151222-0E8B6191-CF19-475A-BC5E-662E17BE3358Q40138153-783638CC-C096-4148-AD37-136B40A8C160Q40478722-EE17533E-F27C-4710-A725-DB92389ED554Q41559604-A2061B5A-81B2-4011-8649-91241350CDE3Q42077528-28CC77CE-688F-40BA-845B-0FD3A84E9626Q42646749-1B38FB1E-CFCC-4F8E-B517-23ADD0039CCFQ44334640-6939F6CE-5C70-4322-A0BE-EE7DD324F4FCQ44344083-00587838-79CB-48A2-B301-7C421B65EA70Q44349980-EEE54647-7637-4389-956A-64F769F2159FQ44350305-2DF7F2FF-CDF8-4B4E-BDA4-CB5CDE1C1A99Q47676192-C199AA38-15CE-493C-816B-D877374C07E4Q47953985-61E54877-92B7-4E52-B286-B327F8728E03Q48105548-75AACF41-0698-488C-985D-61357B059F9EQ48707464-0272BA17-18AF-4121-B3E1-6878FE441202Q52592793-0435115B-1294-4E60-8007-54CBF312BFDFQ55437405-91528050-F096-4C98-B658-87FE959C6067
P2860
Opioid-induced preconditioning: recent advances and future perspectives.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Opioid-induced preconditioning: recent advances and future perspectives.
@ast
Opioid-induced preconditioning: recent advances and future perspectives.
@en
type
label
Opioid-induced preconditioning: recent advances and future perspectives.
@ast
Opioid-induced preconditioning: recent advances and future perspectives.
@en
prefLabel
Opioid-induced preconditioning: recent advances and future perspectives.
@ast
Opioid-induced preconditioning: recent advances and future perspectives.
@en
P2093
P1476
Opioid-induced preconditioning: recent advances and future perspectives.
@en
P2093
Eric R Gross
Garrett J Gross
Jason N Peart
P304
P356
10.1016/J.VPH.2005.02.003
P577
2005-03-17T00:00:00Z